Page last updated: 2024-12-10

beta-2'-deoxythioguanosine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

beta-2'-deoxythioguanosine: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID3000603
CHEMBL ID3250476
SCHEMBL ID531274
SCHEMBL ID9634767
MeSH IDM0055942

Synonyms (58)

Synonym
beta-thioguanine deoxyriboside
2-amino-9-(2-deoxy-beta-d-erythro-pentofuranosyl)-1,9-dihydro-6h-purine-6-thione
nsc-71261
guanosine, 2'-deoxy-6-thio-
2'-desoxy-6-thioguanosine
thio
6-mercaptoguaninedeoxyriboside
thioguanine deoxyriboside
thiodeoxyguanosine
2'-deoxythioguanosine
789-61-7
nsc71261
2-amino-9-(2-deoxy-.beta.-d-erythropentofuranosyl)-9h-purine-6(1h)-thione
2-amino-9-[(2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-1h-purine-6-thione
hsdb 7074
tgdr
nci-c01581
brn 1224220
beta-2'-deoxy-6-thioguanosine monohydrate
beta-2'-deoxythiol guanosine
beta-tgdr
thioguanine 9betad-2'-deoxyriboside
beta-2'-deoxythioguanosine
b-tgdr
2'deoxy-6-thioguanosine
ccris 195
thioguanine deoxyriboside (van)
9h-purine-6(1h)-thione, 2-amino-9-(2-deoxy-beta-d-erythro-pentofuranosyl)-
beta-thioguanidine deoxyriboside
2-amino-9-[(2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-3h-purine-6-thione
6-thio-2'-deoxyguanosine
kr0rfb46df ,
unii-kr0rfb46df
S7757
2'-deoxy-6-thio guanosine
CHEMBL3250476
2'-deoxy-6-thioguanosine
SCHEMBL531274
6-thio-dg
SCHEMBL9634767
AC-32335
DTXSID4021345
beta-thioguanosine deoxyriboside
2-amino-9-[(2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6,9-dihydro-1h-purine-6-thione
2-amino-9-(2-deoxy-.beta.-d-erythro-pentofuranosyl)-6-mercaptopurine
30241-92-0
HY-18762
CS-0014289
2-amino-9-((2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-1h-purine-6(9h)-thione
6-thio-dg;|a-tgdr
6-thio-2 inverted exclamation marka-deoxyguanosine
mfcd00672275
CCG-267279
MS-24022
6-thio-dg;-tgdr
??tgdr
F88129
2'-ddeoxy-6-thio-guanosine

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
"4 mg/kg, 200 mg/m2, 200 microCi total) was administered to five patients; the radiolabel in the plasma declined with an initial half-life (t1/2) of 14 min and a terminal t1/2 of 19."( Pharmacokinetics and metabolism of beta-2'-deoxythioguanosine and 6-thioguanine in man.
Benvenuto, JA; Bodey, GP; Gottlieb, JA; Loo, TL; Lu, K; Rosenblum, MG, 1982
)
0.54

Compound-Compound Interactions

ExcerptReferenceRelevance
"In a randomized multi-institutional trial of the Eastern Cooperative Oncology Group, 316 patients with advanced measurable colorectal adenocarcinoma were treated with a weekly schedule of 5-fluorouracil given orally and intravenously with oral-5-fluorouracil in combination with cyclophosphamide or 6-thioguanine, or with oral Methyl CCNU administered once every eight weeks."( Chemotherapy of advanced measurable colon and rectal carcinoma with oral 5-fluorouracil, alone or in combination with cyclophosphamide or 6-thioguanine, with intravenous 5-fluorouracil or beta-2'-deoxythioguanosine or with oral 3(4-methyl-cyclohexyl)-1(2-
Carbone, P; Conroy, JF; Douglass, HO; Lavin, PT; Woll, J, 1978
)
0.45
"Beta-thioguanine deoxyriboside (betaTGdR) is a purine nucleoside derivative which was studied alone or in combination with arabinosyl cytosine (Ara-C) in patients with solid tumors and acute leukemia."( Clinical studies of beta-thioguanine deoxyriboside alone and in combination with arabinosyl cytosine.
Bodey, GP; Freireich, EM; McCredie, KB; Whitecar, JP, 1976
)
0.26
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (5)

Assay IDTitleYearJournalArticle
AID1133842Inhibition of RNA synthesis in mouse L1210 cells assessed as inhibition of tritiated uridine incorporation into nucleic acids1977Journal of medicinal chemistry, Mar, Volume: 20, Issue:3
Potential antitumor agents. Some sulfur-substituted derivatives of alpha- and beta-2'-deoxythioguanosine.
AID1133835Antitumor activity in mouse L1210 cells allografted in mouse assessed as increase in survival time at optimal dose administered qd on days 1 to 5 of challenge relative to control1977Journal of medicinal chemistry, Mar, Volume: 20, Issue:3
Potential antitumor agents. Some sulfur-substituted derivatives of alpha- and beta-2'-deoxythioguanosine.
AID1133841Inhibition of DNA synthesis in mouse L1210 cells assessed as inhibition of tritiated thymidine incorporation into nucleic acids1977Journal of medicinal chemistry, Mar, Volume: 20, Issue:3
Potential antitumor agents. Some sulfur-substituted derivatives of alpha- and beta-2'-deoxythioguanosine.
AID1133836Antitumor activity in mouse L1210 cells allografted in mouse assessed as increase in survival time at optimal dose administered qd on days 1 to 9 of challenge relative to control1977Journal of medicinal chemistry, Mar, Volume: 20, Issue:3
Potential antitumor agents. Some sulfur-substituted derivatives of alpha- and beta-2'-deoxythioguanosine.
AID1133840Antitumor activity in mouse P388 cells allografted in mouse assessed as increase in survival time at optimal dose administered qd on days 1 to 9 of challenge relative to control1977Journal of medicinal chemistry, Mar, Volume: 20, Issue:3
Potential antitumor agents. Some sulfur-substituted derivatives of alpha- and beta-2'-deoxythioguanosine.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (25)

TimeframeStudies, This Drug (%)All Drugs %
pre-199017 (68.00)18.7374
1990's3 (12.00)18.2507
2000's1 (4.00)29.6817
2010's4 (16.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.49

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.49 (24.57)
Research Supply Index3.43 (2.92)
Research Growth Index4.92 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.49)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials5 (20.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other20 (80.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]